The dendritic cell by nature is indication agnostic. The process application of when and where to utilize them as a treatment option and how to properly activate them is all that is needed to be understood at the most basic level. NWBO is organizing the proof positive of this to present to regulators in my opinion. I think 27 years of research and observations by some of the top minds in oncology and neuro oncology in the world just might do the trick ; ). Best wishes.
Market Data 
Markets 
AI
